Physician profile
Michael Bortz
NPI 1497166243
$5,016.33
in general payments reported to CMS, 2019-2025
11 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $180 · 2022: $4,399 · 2023: $207 · 2024: $76.62 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $438.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,625.06 | 2021-2023 | Da Vinci Surgical System |
| Medtronic, INC. | $133.60 | 2023-2025 | Pteye Parathyroid Detection System, Signia |
| Becton, Dickinson and Company | $41.22 | 2024 | Arista Ah Flexitip, Phasix Mesh |
| Merit Medical Systems INC | $41.16 | 2025 | Savi Scout |
| Dilon Technologies, INC. | $36.62 | 2023-2024 | Hemoblast Bellows |
| Davol INC. | $35.11 | 2025 | Phasix Mesh |
| Endomagnetics LTD | $28.78 | 2021 | |
| Ethicon US, LLC | $28.29 | 2025 | Echelon Flex, Proximate |
| Cardinal Health 414 LLC | $17.57 | 2024 | Kit For The Preparation of Lymphoseek (Technetium Tc 99m Tilmanocept) |
| Checkpoint Surgical, INC | $14.58 | 2023 | Checkpoint Stimulators |
| Teleflex LLC | $14.34 | 2023 | Weck |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bortz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.